banner
SUNPHARMA.NS image

Sun Pharmaceutical Industries Limited

SUNPHARMA.NS

1700

INR
+13.80
(+0.82%)
Day's range
1691.3
1748.5
52 wk Range
1377.2
1960.35

Key Statistics

Previous Close
1.69K
Open
1711
Day's Range
1691.3 - 1748.5
52 wk Range
1377.2 - 1960.35
Volume
6.99M
Average Volume
2.40M
Market Cap
4.08T
Shares Outstanding
2.40B
Revenue
477.58B
Net Income
95.76B
EPS
47.74
P/E Value
35.61
Next Earnings Date
May 22, 2025
Dividend (Yield)
0.91%
Return on Assets
12.98%
Return on Equity
17.38%
Gross Profit Margin
61.74%
Price/Book
5.90
EBITDA
138.36B
EV/EBITDA (TTM)
24.95
P/BV Value
5.90
P/S Value
7.94
Beta
0.387

Sun Pharmaceutical Industries Limited Company Profile

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Employes
43000
Market
IN